Characteristics | UEC | UCCC | USC | UMC | P | Pa | Pb | Pc |
---|---|---|---|---|---|---|---|---|
n | 396 | 34 | 106 | 34 | Â | Â | Â | Â |
Age, mean ± sd | 54.705 ± 8.7763 | 64.088 ± 9.0833 | 61.453 ± 8.5213 | 58 ± 5.1757 |  < 0.001 |  < 0.001 |  < 0.001 | 0.002 |
Menopause, n (%) |  |  |  |  |  < 0.001 |  < 0.001 |  < 0.001 |  < 0.001 |
 Yes | 235 (59.3%) | 31 (91.2%) | 95 (89.6%) | 32 (94.1%) |  |  |  |  |
 No | 150 (37.9%) | 3 (8.8%) | 10 (9.4%) | 2 (5.9%) |  |  |  |  |
 Unknown | 11 (2.8%) | 0 (0%) | 1 (0.9%) | 0 (0%) |  |  |  |  |
 BMI, median (IQR) | 25.462 (23.422, 28.134) | 26.531 (22.481, 28.125) | 24.654 (22.638, 27.447) | 25.1 (23.508, 26.667) | 0.480 | 0.933 | 0.162 | 0.430 |
Stage, n (%) |  |  |  |  |  < 0.001 |  < 0.001 |  < 0.001 |  < 0.627 |
 IV | 2 (0.5%) | 1 (2.9%) | 11 (10.4%) | 0 (0%) |  |  |  |  |
 III | 27 (6.8%) | 6 (17.6%) | 26 (24.5%) | 4 (11.8%) |  |  |  |  |
 II | 6 (1.5%) | 2 (5.9%) | 7 (6.6%) | 1 (2.9%) |  |  |  |  |
 I | 361 (91.2%) | 21 (61.8%) | 59 (55.7%) | 29 (85.3%) |  |  |  |  |
 Unknown | 0 (0%) | 4 (11.8%) | 3 (2.8%) | 0 (0%) |  |  |  |  |
Myometrial infiltration (> = 1/2), n (%) |  |  |  |  |  < 0.001 | 0.090 |  < 0.001 | 0.182 |
 Yes | 70 (17.7%) | 4 (11.8%) | 49 (46.2%) | 10 (29.4%) |  |  |  |  |
 No | 297 (75%) | 24 (70.6%) | 50 (47.2%) | 23 (67.6%) |  |  |  |  |
 Unknown | 29 (7.3%) | 6 (17.6%) | 7 (6.6%) | 1 (2.9%) |  |  |  |  |
Cervix involvement, n (%) |  |  |  |  |  < 0.001 | 0.142 |  < 0.001 | 0.073 |
 Yes | 18 (4.5%) | 4 (11.8%) | 23 (21.7%) | 3 (8.8%) |  |  |  |  |
 No | 333 (84.1%) | 25 (73.5%) | 80 (75.5%) | 31 (91.2%) |  |  |  |  |
 Unknown | 45 (11.4%) | 5 (14.7%) | 3 (2.8%) | 0 (0%) |  |  |  |  |
Lymph node metastasis, n (%) |  |  |  |  |  < 0.001 | 0.008 |  < 0.001 | 0.053 |
 Yes | 19 (4.8%) | 6 (17.6%) | 31 (29.2%) | 2 (5.9%) |  |  |  |  |
 No | 299 (75.5%) | 23 (67.6%) | 62 (58.5%) | 31 (91.2%) |  |  |  |  |
 Unknown | 78 (19.7%) | 5 (14.7%) | 13 (12.3%) | 1 (2.9%) |  |  |  |  |